SelectScience Interviews
Search results for "slas europe 2018"
25
Selected Filters:
SelectScience Interviews
GC-MS for Trace Contaminant Screening in Complex Samples
SelectScience Interviews
Discover a Cutting-Edge Open Access Mass Spectrometry Core Facility
SelectScience Interviews
FIFA and WADA Management of Anti-Doping Testing for the World Cup
SelectScience Interviews
Automated Droplet Generator Simplifies Droplet Digital PCR Workflow
SelectScience Interviews
Powerful Analysis of 3D and 4D Microscopy Datasets with Imaris Software from Bitplane
SelectScience Interviews
The Future of Confocoal Microscopy: John White, University of Wisconsin
SelectScience Interviews
Landmark Troponin Assay to Give Results at the Point-of-Care
SelectScience Interviews
Advanced Automated Systems for IFA slides, Blot Strips and ELISA
SelectScience Interviews
New Ultra-Sensitive Detection of Protein on Surgical Instruments
SelectScience Interviews
New High Performance Shaker - Greater Weights for Larger Sieves
Product News
Extensive Range of Lab Equipment on Show
SelectScience Interviews
New features of Biospectrometer
SelectScience Interviews
Win a New BMG LABTECH Full Spectrum Absorbance Microplate Reader
SelectScience Interviews
Tecan's HydroSpeed for optimized cell washing, beads and ELISAs.
SelectScience Interviews
New Automated Solutions and BenchBot Robot from Agilent
SelectScience Interviews
Automated Electrophysiology for High Throughput Analysis
SelectScience Interviews
Measure DNA, RNA & Protein with All-in-One System
SelectScience Interviews
Economical Freezer and Bioreactor from Eppendorf
SelectScience Interviews
New Microplate Dispenser for any Volume, any Format
SelectScience Interviews
New Low Bleed GC Column and Flow Meter
Industry News
CHMP Recommends EU Approval of Roche’s Tecentriq in Combination with Abraxane as an Initial treatment for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer
Recommendation based on the results of IMpassion130 study in triple-negative breast cancer, an aggressive type of breast cancer with high unmet medical need